Stereochemistry Topic of 33rd Leermakers Symposium

Olivia DrakeMay 2, 20054min

Posted 05/02/05

More than 150 guests, many from academia and the pharmaceutical industry, attended the 33rd Peter A. Leermakers Symposium May 5 at the Exley Science Center.

The annual, one day meeting brings together internationally recognized chemists for a day of intensive examination of a particular subject in chemistry.

This year’s symposium, titled “Chirality,” united scientists working in the general area of stereochemistry. The speakers have played a fundamental role in the control and understanding of stereochemistry.

Stereochemistry is a property that certain molecules have that can make two molecules behave completely differently as drugs, even though the structures of the two molecules look very similar. Stereochemistry depends on the symmetry of a molecule and is very difficult to control when one is synthesizing the molecule.

Speakers of the day-long event included Judith Brown, vice president for Academic Affairs and provost; Michael Frisch, visiting scholar in chemistry; Professor Kendall Houk from the University of California, Los Angeles; Professor David Evans from Harvard University; Edward Grabowski from Merck Research Laboratories; Professor Eric Jacobsen from Harvard University; and Professor Geoffrey Coates from Cornell University.

The speakers presented results related to asymmetric catalysis, the synthesis of stereoregular polymers, the computer modeling of stereoselective reactions and the use of spectroscopy.

“These scientists are all at the very top of their fields and have been recognized by numerous awards,” says Michael Calter, associate professor of chemistry and chair of the Leermakers Symposium.

The first symposium was held in 1972 on the chemistry of vitamin B12 and featured the late Robert B. Woodward, who reported on the just-completed total synthesis of this complex molecule. Since then topics have included natural biology, theoretical chemistry, extraterrestrial chemistry and chemical reaction dynamics.

The symposium was funded by Bristol-Myers Squibb, Pharmaceutical Research Institute, Merck Research Labs and Pfizer Global Research Division.

By Olivia Drake, The Wesleyan Connection editor

The Speakers Judith Brown, vice president for Academic Affairs and provost, Wesleyan University

Professor Geoffrey Coates, Cornell University spoke on “New Catalysts for Constructing Small Molecules and Polymers of Defined Stereochemistry.”

Professor Eric Jacobsen of Harvard University spoke on “Seeking General Asymmetric Catalysts.”

Michael Frisch, Visiting Scholar in Chemistry spoke on “Spectroscopy of Chiral Molecules.”

Professor Edward Grabowski of Merck Research Laboratories spoke on “Novel, Asymmetric Hydrogenations.”

Professor Kendall Houk, University of California, Los Angeles spoke on the “Theory and Modeling of Stereoselectivity”

Professor David Evans spoke on “From Crystal Structures to Chiral Catalysts.”